NVOS Stock Price Prediction: Forecast & Risks Explained

Novo Integrated Sciences (NASDAQ: NVOS) has spent the last few years as one of the more talked-about penny stocks on Reddit and Stocktwits, and the question “where is NVOS headed next” keeps coming up. If you searched for an NVOS stock price prediction hoping for a clean number, the honest answer is messier than that. Forecasting models disagree with each other by orders of magnitude, the stock has already been through one reverse split, and the company’s market cap now sits in the tens of thousands of dollars rather than the millions.

This guide walks through where NVOS trades today, what different forecasting tools currently predict, the factors actually driving the price, and the risks anyone should weigh before treating any of these numbers as a plan. For a closer look at the day-to-day price action, our NVOS price tracker is updated more frequently than this article.

NVOS Stock: The Current Picture

Novo Integrated Sciences provides physiotherapy, chiropractic care, and other primary health services through its subsidiaries, mainly in Canada, and also develops health-related products. It trades on Nasdaq under the ticker NVOS, and it underwent a 1-for-10 reverse stock split in November 2023 after the share price fell below Nasdaq’s minimum listing requirements.

Since that split, the stock has kept sliding. Shares that opened 2025 around $0.05 had dropped to roughly $0.001 to $0.005 by mid-2025, a decline of more than 90% in a matter of months. The 52-week range has swung as wide as fractions of a cent up to roughly $1, and daily trading volume is thin enough that even small trades can move the price sharply.

Because the float and market cap are so small, NVOS behaves less like a typical growth stock and more like a speculative micro-cap where small news events, dilution, or short-term trading interest can swing the price by double digits in a single session.

NVOS Stock Price Prediction: What the Models Say

This is where things get genuinely confusing for anyone researching the stock, and it’s worth understanding why before looking at any single number.

Automated forecasting sites pull historical price data and run it through technical or machine-learning models. For a stock with NVOS’s trading history, those models produce wildly different outputs depending on how they treat the reverse split, recent volume, and volatility:

The takeaway is not any single number in that table. It’s that no two models agree, and several of the long-range “rebound” figures imply gains so large they aren’t grounded in anything the company has actually announced. That mismatch alone tells you these are statistical extrapolations, not informed opinions about Novo Integrated Sciences‘ business. For a broader breakdown of these projections, see our dedicated NVOS stock forecast page and the NVOS stock price target analysis.

Why NVOS Is So Hard to Forecast

A few structural factors make standard forecasting tools unreliable for this particular stock:

Extremely low share price: When a stock trades in fractions of a cent, percentage swings look enormous even when the actual dollar movement is tiny. A move from $0.001 to $0.002 is “up 100%” but represents a change of one-tenth of a cent.

Thin liquidity: Average daily volume has been reported in the tens of thousands of shares, which is low enough that a single trade can shift the quoted price without reflecting any real change in company value.

Dilution risk: Micro-cap companies burning cash often raise money by issuing new shares, which increases the share count and puts downward pressure on price regardless of what forecasting models predict.

History of reverse splits: A reverse split changes the share count and price overnight, which throws off models trained on pre-split data unless they adjust for it correctly. This is likely a big part of why some forecast sites show numbers that look completely disconnected from the current price.

Factors That Could Actually Move NVOS Stock

Setting aside the algorithmic forecasts, a handful of real-world factors tend to drive short-term price action in stocks like this one:

• Quarterly earnings and cash position — whether the company is burning through cash faster or slower than expected
• Nasdaq listing compliance — any risk of delisting, or steps taken to regain compliance, tends to move the price sharply in either direction
• New financing or share issuance — additional capital raises usually dilute existing shareholders and weigh on the price
• Retail trading sentiment — activity on forums like Reddit and Stocktwits can create short bursts of volume and volatility unrelated to fundamentals
• Sector-wide healthcare stock trends — broader moves in small-cap healthcare names sometimes pull NVOS along with them

You can see how retail sentiment has been trending on our NVOS stock Reddit roundup, which tracks what traders are actually saying rather than just what the algorithms predict.

Bull Case vs. Bear Case

The bull case rests on the idea that Novo Integrated Sciences still operates real clinics and product lines generating revenue, and that any positive catalyst, a financing deal, a partnership, or a turnaround in cash flow, could spark a sharp rally given how few shares are needed to move the price. Micro-caps at these price levels have occasionally produced multi-hundred-percent short-term rallies on relatively modest news.

The bear case is more straightforward: persistent revenue challenges, thin institutional support, continued share dilution, and a stock price that has fallen for multiple consecutive years despite periodic bounces. Several technical models currently rate the stock a sell based purely on trend and momentum.

Neither case is a prediction. They’re the two ends of a range that any realistic assessment of NVOS needs to hold at once.

Should You Buy NVOS Stock?

This isn’t a recommendation to buy or sell, and no forecast, including the ones cited above, should be treated as one. NVOS is a high-risk, high-volatility micro-cap stock. That profile can appeal to traders comfortable with the possibility of losing most or all of their position in exchange for a shot at outsized gains, but it’s a poor fit for anyone looking for stability or income.

Before making any decision, it’s worth reading the company’s actual SEC filings rather than relying only on third-party price targets, checking current volume and float on a live quote, and sizing any position so that a total loss wouldn’t meaningfully affect your finances. Our analysis of NVOS stock’s volatility goes deeper into the specific risk factors at play, and the comprehensive overview of NVOS covers the company’s business segments in more detail.

FAQs

Is NVOS stock a good investment in 2026? 

NVOS is a speculative micro-cap with a market cap under $150,000 and a multi-year downtrend. It may suit traders comfortable with high risk, but it isn’t a stock for anyone seeking stability or predictable returns.

Why do NVOS price predictions vary so much between websites? 

Different forecasting tools use different models, and several haven’t fully adjusted for the 2023 reverse stock split or the stock’s extremely thin trading volume. That produces wildly inconsistent long-range projections across platforms.

Will NVOS stock go up or down? 

No one can say with certainty. Short-term technical models currently lean bearish based on trend and volume, while any positive company news could trigger a sharp bounce given how small the float is. Treat any specific price prediction as a rough estimate, not a guarantee.

Did NVOS stock do a reverse split? 

Yes. Novo Integrated Sciences completed a 1-for-10 reverse split on November 7, 2023, after its share price fell below Nasdaq’s minimum listing requirements.

Where can I check the current NVOS stock price? 

Live quotes are available through your brokerage or a financial data site. Our NVOS price update page also tracks recent movement and context around the current price.

Is NVOS at risk of being delisted from Nasdaq? 

Given the stock’s price and market cap, Nasdaq compliance is a real ongoing concern for the company. Any compliance updates, whether positive or negative, tend to move the stock sharply, so it’s worth monitoring official filings directly.

Conclusion

Searching for an NVOS stock price prediction turns up more noise than signal right now. Algorithmic models disagree with each other by huge margins, the company’s tiny market cap and thin volume make the stock unusually reactive to small trades, and the 2023 reverse split has muddied a lot of the historical data these tools rely on. What’s clear is the risk profile: NVOS is a volatile, low-priced micro-cap stock where fundamentals, dilution, and Nasdaq compliance matter far more than any single forecast number.

If you’re tracking this stock, lean on primary sources, actual filings, current volume, and listing status, rather than any one price target. Keep an eye on our NVOS stock forecast coverage for updates as new data comes in.